Equities

Spectral Medical Inc

Spectral Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.37
  • Today's Change-0.004 / -0.94%
  • Shares traded10.00k
  • 1 Year change+62.64%
  • Beta0.9276
Data delayed at least 15 minutes, as of Jul 18 2024 14:40 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX has been on the market in many countries outside the United States and has been used in more than 340,000 patients to date. It is engaged in the development of biochemical markers for the clinical syndrome known as septic shock. It is also continuing its legacy business of manufacturing and selling certain reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

  • Revenue in CAD (TTM)1.74m
  • Net income in CAD-17.93m
  • Incorporated2005
  • Employees29.00
  • Location
    Spectral Medical Inc135 The West Mall, Unit 2TORONTO M9C 1C2CanadaCAN
  • Phone+1 (416) 626-3233
  • Fax+1 (416) 626-3233
  • Websitehttps://spectraldx.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Marinus Pharmaceuticals Inc28.29m-145.34m76.36m165.00------2.70-2.64-2.640.5142-0.29920.15540.85363.72171,442.40-79.82-49.64-96.93-57.7691.22---513.80-518.962.93-13.621.29--21.63---613.59--7.47--
CEL-SCI Corp0.00-29.95m77.45m43.00--5.41-----0.6304-0.63040.000.26450.00-------87.78-70.19-103.56-78.31-------15,434.151.18-39.260.4319------13.99--223.59--
Eagle Pharmaceuticals Inc257.55m11.95m77.66m134.006.560.31072.380.30150.9110.91119.5919.250.65491.552.561,922,022.003.046.374.047.9869.8471.864.647.851.673.550.21780.0084.565.99513.14-8.42-49.05--
Journey Medical Corp80.00m-4.16m80.29m58.00--8.82--1.00-0.3095-0.30954.130.64980.9852.274.281,379,276.00-5.12---17.85--66.22---5.20--0.93570.40490.5773--7.48--87.00------
LifeVantage Corp205.45m3.60m81.41m248.0022.933.0411.190.39630.27960.279616.012.113.202.5391.56828,443.605.6011.658.5118.9279.3282.201.753.421.01--0.005.233.410.9838-18.59-18.77-7.98--
SCYNEXIS Inc140.39m101.33m81.98m29.001.081.11--0.5842.012.012.891.961.49--136.304,840,862.00107.48-30.02175.37-36.3588.97--72.18-86.76--193.810.1433--2,652.72252.64206.74------
CASI Pharmaceuticals Inc28.94m-30.48m84.23m176.00--5.45--2.91-2.28-2.282.161.150.39541.003.41164,437.50-40.88-34.75-59.15-46.9158.3655.98-103.40-153.723.25-76.700.5458---21.41--34.27--14.65--
Zhong Yuan Bio-Technology Holdings Ltd2.49m232.02k88.22m35.00391.37348.44--35.380.0128-0.01760.13950.01430.8583-1.613.2571,253.436.49--19.10--106.30--7.57--0.83092.530.8593---28.60---148.37------
Eton Pharmaceuticals Inc34.30m913.00k92.23m30.00106.125.9549.772.690.03380.03381.330.60311.258.419.641,143,467.003.34-46.225.72-58.2066.2472.162.66-76.861.43--0.2447--48.90--89.62--26.85--
Cellectar Biosciences Inc0.00-50.98m93.92m20.00--9.56-----3.17-3.170.000.7890.00----0.00-176.58-83.69-295.36-99.80-----------4.810.00-------32.80--17.55--
Elutia Inc25.05m-49.46m98.37m54.00------3.93-2.35-2.341.24-2.070.52192.064.27463,833.30-103.05-42.93-599.50-79.3442.0143.32-197.48-64.160.5499-1.36-----49.69-8.71-25.39--12.74--
Spectral Medical Inc1.27m-13.11m98.44m29.00------77.59-0.047-0.04730.0046-0.05270.25073.232.1943,752.43-258.89-109.65-18,581.35-175.3537.8563.74-1,032.89-445.720.3287-2.56-----4.14-16.08-104.12--31.53--
Telomir Pharmaceuticals Inc0.00-18.84m117.25m1.00--38.87-----0.6889-0.68890.000.1019------0.00-------------------0.89860.00-------1,430.39------
Data as of Jul 18 2024. Currency figures normalised to Spectral Medical Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.